Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-15

Clinical Trial Update: A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 study to test BI 1815368 for diabetic macular edema is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BI 1815368

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Macular Edema | Phase 2 | Status: RECRUITING